本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

PTC Therapeutics Inc.

68.31
+0.20000.29%
盘后68.310.00000.00%16:47 EDT
成交量:81.60万
成交额:5,575.28万
市值:54.26亿
市盈率:8.85
高:69.28
开:67.86
低:67.57
收:68.11
52周最高:69.88
52周最低:35.95
股本:7,943.81万
流通股本:6,501.02万
量比:1.14
换手率:1.26%
股息:- -
股息率:- -
每股收益(TTM):7.72
每股收益(LYR):-4.7276
净资产收益率:-7740.12%
总资产收益率:23.81%
市净率:-26.27
市盈率(LYR):-14.45

数据加载中...

2025/10/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/19

重要事件披露

Form 8-K - Current report
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/07

重要事件披露

Form 8-K - Current report
2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/07

重要事件披露

Form 8-K - Current report
2025/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/28

重要事件披露

Form 8-K - Current report